Cargando…

Prognostic significance of pseudocapsule status in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

BACKGROUND: We sought to determine whether pseudocapsule (PS) features have prognostic implications in patients with metastatic renal cell carcinoma (mRCC). METHODS: We retrospectively reviewed 231 patients diagnosed with mRCC and treated with tyrosine kinase inhibitors; 188 patients with data avail...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xi, Wei, Hou, Yingyong, Hu, Xiaoyi, Xia, Yu, Jiang, Shuai, Wang, Hang, Bai, Qi, Hou, Jun, Guo, Jianming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661261/ https://www.ncbi.nlm.nih.gov/pubmed/34984179 http://dx.doi.org/10.21037/tau-21-429

Ejemplares similares

No Detection of Pseudocapsule of Tumor-Parenchyma Interface on Multidetector Computed Tomography (MDCT) Images: Clinical Significance and Histological Reflections in Renal Cell Carcinoma
por: Xi, Wei, et al.
Publicado: (2021)

Pseudocapsule and pseudocapsule-based extracapsular resection in pituitary neuroendocrine tumors
por: Wang, Xiao Bin, et al.
Publicado: (2022)

A preoperative nomogram predicting the pseudocapsule status in localized renal cell carcinoma
por: Hu, Jiao, et al.
Publicado: (2020)

Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
por: Xia, Yu, et al.
Publicado: (2017)

Checkpoint molecule PD-1-assisted CD8(+) T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
por: Yao, Jiaxi, et al.
Publicado: (2018)

Immunohistochemical Localization of Nerve Fibers in the Pseudocapsule of Fibroids
por: Sun, Y., et al.
Publicado: (2014)

Characteristics of peritumoral pseudocapsule in small renal cell carcinoma and its influencing factors
por: Dong, Xiang, et al.
Publicado: (2022)

Surgical Management of Neurovascular Bundle in Uterine Fibroid Pseudocapsule
por: Tinelli, Andrea, et al.
Publicado: (2012)

Immunoscore System for Predicting Clinical Outcome of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
por: Yao, Jia-Xi, et al.
Publicado: (2018)

Prognostic significance of platelet–lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer
por: Park, Tae Ju, et al.
Publicado: (2016)

Submucous Fibroids, Fertility, and Possible Correlation to Pseudocapsule Thickness in Reproductive Surgery
por: Tinelli, Andrea, et al.
Publicado: (2018)

Pseudocapsule-Based Resection for Pituitary Adenomas via the Endoscopic Endonasal Approach
por: Zhou, Yuefei, et al.
Publicado: (2022)

Systemic Inflammatory Biomarkers Predict Survival of Patients Treated With Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
por: Wang, Zhaojuan, et al.
Publicado: (2023)

Endoscopic endonasal surgery for non-invasive pituitary neuroendocrinology tumors with incomplete pseudocapsule
por: Zhang, Gang, et al.
Publicado: (2023)

MRI as a tool to assess surgical margins and pseudocapsule features directly following partial nephrectomy for small renal masses
por: van Oostenbrugge, Tim J., et al.
Publicado: (2018)

Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
por: Janisch, Florian, et al.
Publicado: (2021)

Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis
por: Xu, Yawei, et al.
Publicado: (2019)

Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors
por: Wu, Jialu, et al.
Publicado: (2020)

Detection of a peritumoral pseudocapsule in patients with renal cell carcinoma undergoing robot-assisted partial nephrectomy using enhanced MDCT
por: Toguchi, Makoto, et al.
Publicado: (2021)

Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
por: Roviello, Giandomenico, et al.
Publicado: (2022)

The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors
por: Zhang, Haoran, et al.
Publicado: (2020)

Eosinophil percentage elevation as a prognostic factor for overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
por: Wang, Hong-Kai, et al.
Publicado: (2016)

Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis
por: Liu, Yu, et al.
Publicado: (2019)

Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma
por: Bai, Qi, et al.
Publicado: (2016)

The Use of Micro Retractor in Endoscopic Endonasal Posterior Pseudocapsule Resection of Pituitary Macroadenoma. Technical Note
por: Xie, Tao, et al.
Publicado: (2021)

Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients
por: Xu, Xianglai, et al.
Publicado: (2023)

Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
por: Catalano, Martina, et al.
Publicado: (2022)

IgG4-related systemic disease mimicking renal pelvic cancer: a rare case
por: Wang, Yiwei, et al.
Publicado: (2014)

Tyrosine kinase – Role and significance in Cancer
por: Paul, Manash K., et al.
Publicado: (2004)

Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor
por: Teishima, Jun, et al.
Publicado: (2021)

CONCERNING THE SURFACES OF CELLS OF STAPHYLOCOCCUS PYOGENES : I. A PSEUDOCAPSULATION PHENOMENON UNDER CERTAIN EXPERIMENTAL CONDITIONS
por: Sall, Theodore, et al.
Publicado: (1961)

Fat ring sign and tumoral pseudocapsule sign in idiopathic mesenteric panniculitis complicated by protein‐losing enteropathy
por: Hori, Hiroshi, et al.
Publicado: (2020)

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2016)

Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
por: Stühler, Viktoria, et al.
Publicado: (2016)

Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors
por: Cho, Daniel C
Publicado: (2013)

Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations
por: Wang, Kun, et al.
Publicado: (2023)

Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma
por: Ishihara, Hiroki, et al.
Publicado: (2017)

Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma
por: Busch, Jonas, et al.
Publicado: (2011)

Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma
por: Lai, Yongchang, et al.
Publicado: (2018)

The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma
por: Buti, Sebastiano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1tv7cc9qgj4efqd2bgal7sp113